Cell identity was validated using human antibodies and probes consistent with a myeloma origin for example, CD45dim/CD38+/CD56+/CD19‐/CD28+/CD138+or−/cLambda+/cKaappa−. The gene discussed is NCAM1; the disease is plasma cell myeloma.